Cognitive Behavioral Therapy for Mental Health

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, Los Angeles
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this study is to understand why certain treatments help people reduce repetitive negative thinking (RNT), which is common in many mental health problems. We want to:

1. Figure out what actually causes repetitive negative thinking to decrease when people use cognitive-behavioral therapy (CBT).

2. Find out which parts of RNT-focused CBT are the most important - the parts that truly make a difference in reducing RNT.

The main result we will look at is how much a person's repetitive negative thought patterns change from the start of the study to the end of treatment (16 weeks). We will measure this using the Perseverative Thinking Questionnaire at baseline and week 16.

Are You a Good Fit for This Trial?

This trial is for adults experiencing anxiety, depression, or repetitive negative thinking. Participants should be willing to try therapy techniques and complete questionnaires over a 16-week period.

Inclusion Criteria

Access to a suitable smartphone/device (iPhone 8+ running iOS 16.4 or higher, or Android version 8 or higher)
Able to provide a valid Imperial Valley College email address
Access to internet
See 2 more

Exclusion Criteria

Self-reported current or past diagnosis or treatment for Bipolar disorder
Self-reported current or past diagnosis or currently receiving, or waiting to receive, treatment for substance abuse/dependence
Self-reported current diagnosis or currently receiving, or waiting to receive, treatment for alcohol abuse/dependence
See 5 more

What Are the Treatments Tested in This Trial?

Interventions

  • Calming Minds Study

Trial Overview

The study tests different parts of cognitive-behavioral therapy (CBT) aimed at reducing repetitive negative thoughts. Techniques include being present, breaking habits, being specific and kind, plus psychoeducation. Changes are measured over 16 weeks.

How Is the Trial Designed?

16

Treatment groups

Experimental Treatment

Active Control

Group I: Break Habit + Be Specific+ Be PresentExperimental Treatment4 Interventions
Group II: Break Habit + Be Specific + Be KindExperimental Treatment4 Interventions
Group III: Break Habit + Be SpecificExperimental Treatment3 Interventions
Group IV: Break Habit + Be PresentExperimental Treatment3 Interventions
Group V: Break Habit + Be Kind + Be PresentExperimental Treatment4 Interventions
Group VI: Break Habit + Be KindExperimental Treatment3 Interventions
Group VII: Break HabitExperimental Treatment2 Interventions
Group VIII: Be Specific + Be PresentExperimental Treatment3 Interventions
Group IX: Be Specific + Be Kind + Be PresentExperimental Treatment4 Interventions
Group X: Be Specific + Be KindExperimental Treatment3 Interventions
Group XI: Be SpecificExperimental Treatment2 Interventions
Group XII: Be PresentExperimental Treatment2 Interventions
Group XIII: Be Kind + Be PresentExperimental Treatment3 Interventions
Group XIV: Be KindExperimental Treatment2 Interventions
Group XV: ALLExperimental Treatment5 Interventions
Group XVI: Psychoeducation OnlyActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Los Angeles

Lead Sponsor

Trials
1,594
Recruited
10,430,000+

University of Exeter

Collaborator

Trials
207
Recruited
1,368,000+